Cargando…
Natural killer cells in obstetric antiphospholipid syndrome
Autores principales: | Huo, Rongxiu, Guo, Qianyu, Hu, Junping, Li, Na, Liu, Hechao, Zhang, Zhaoliang, Mi, Liangyu, Peng, Xinyue, Zhang, Liyun, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276402/ https://www.ncbi.nlm.nih.gov/pubmed/34985021 http://dx.doi.org/10.1097/CM9.0000000000001908 |
Ejemplares similares
-
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
por: Huo, Rongxiu, et al.
Publicado: (2022) -
The Mechanism of Stem Cell Aging
por: Mi, Liangyu, et al.
Publicado: (2022) -
Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases
por: Li, Na, et al.
Publicado: (2020) -
Obstetric antiphospholipid syndrome
por: Antovic, Aleksandra, et al.
Publicado: (2018) -
Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)